🔔 📢 Key Takeaways from the CDDF-ESMO Joint Session, “Regulatory Challenges in Clinical Cancer Drug Development” (16 Sep 2024)
The CDDF & ESMO educational session on "Regulatory Challenges in Clinical Cancer Drug Development" took place on 16 September 2024 at ESMO 2024. In this session, Aaron E. Sosa Mejia (Danish Medicines Agency) and Audrey Wolf (EFPIA) gave presentations followed by a...
![[🔔 📣 Call for pharmaceutical companies to join in the CDDF Diversity Initiative]](https://cddf.org/wp-content/uploads/2024/09/Copy-of-Copy-of-Copy-of-Dark-Purple-and-Blue-Texture-Blur-Circle-Business-Marketing-Presentation-1080x675.jpg)
[🔔 📣 Call for pharmaceutical companies to join in the CDDF Diversity Initiative]
We are delighted to announce that the Cancer Drug Development Forum (CDDF) has launched its initiative on diversity in oncology clinical trials. CDDF cordially invites pharmaceutical companies to participate in this collaborative effort to support the planning and...
ACT EU: Stakeholder Presentation on Critical Use-Cases at MSP Advisory Group Meeting (4 July 2024)
On 4 July 2024, CDDF participated in a stakeholder presentation focused on critical use-cases at Multi-Stakeholder Platform (MSP) Advisory Group meeting. The session aimed to identify and discuss real-world challenges faced by stakeholder groups within the European...
![[🔔 📢 Key Takeaways from the CDDF Webinar on “Bayesian Approaches in Drug Development”]](https://cddf.org/wp-content/uploads/2024/07/Capture-4-1080x675.jpg)
[🔔 📢 Key Takeaways from the CDDF Webinar on “Bayesian Approaches in Drug Development”]
The Cancer Drug Development Forum (CDDF) held a live webinar on Bayesian Approaches in Drug Development on 11 July 2024. In this webinar, Rob Hemmings (Consilium) gave an insightful talk followed by a Q&A discussion moderated by Axel Glasmacher (CDDF) and Eva...
🔔 📢 NEW PUBLICATION: Empowering Effective Biomarker-Driven Precision Oncology: A Call to Action (Lawler et al., 2024)
The Cancer Drug Development Forum (CDDF) is delighted to announce that a white paper, “Empowering Effective Biomarker-Driven Precision Oncology: A Call to Action” has been published in European Journal of Cancer (Vol 209, September 2024). This paper has been developed...
🔔 HMA/EMA Multi-stakeholder Workshop on Artificial Intelligence – 5 Nov 2024
Check out the hybrid joint HMA/EMA multi-stakeholder workshop on Artificial Intelligence (AI) that will be held on 5 November 2024. The objectives of the workshop is to provide an update on the state-of-the-art of AI developments with keynote speakers: Update...